Jyong Biotech (MENS)
Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
News
- Quartr · Sep 7 at 01:35 AM
MENS: MCS-2 stands out for safety and innovation, with early FDA phase III approval positioning for market entry
- PUBT · Sep 3 at 12:02 PM
Jyong Biotech to join StockFan virtual investor non-deal roadshow
- StockTitan · Jul 23 at 06:52 AM
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships | MENS Stock News
- PR Newswire · Jul 3 at 12:00 AM
Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention
- PR Newswire · Jun 1 at 12:00 AM
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
